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Microorganisms are closely associated with the health and welfare of human beings. Whereas some microorganisms are beneficial,
others are detrimental. Bacterial infections often produce inflammation and pains and in some instances, infections result in high
mortality. Any subtle change in the drug molecule, which may not be detected by chemical methods, can be revealed by a change
in the antimicrobial activity and hence microbiological assays are very useful. A series of substituted hydroxy benzophenones
and benzophenone-N-ethyl morpholine ethers were screened for their antibacterial and antifungal activities. Antibacterial activity
against S. aureus, E. aerogenes, M. luteus, K. pneumonia, and S. typhimurium, S. paratyphi-B and P. vulgaris bacterial strains and
antifungal activity againstC. albicans,B. cinerea,M. pachydermatis,C. krusei fungal strains were carried out.The bioassays indicated
that most of the synthesized compounds showed potential antibacterial and antifungal agents.
1. Introduction
Bacteria are extremely pathogenic causing infection and
widespread use of commercially available antibiotics led to
the developed resistance or ability to produce substance
which block the action of antibiotics or change their target
and produce undesirable side effects [1]. Although, a number
of different classes of antibacterial and antifungal agents have
been discovered during the last two decades, the use is limited
due to development of microbial resistance [2]. In recent
decades, problems of multidrug-resistant microorganisms
have reached an alarming level in many countries around
the world. Resistance to a number of antimicrobial agents (b-
lactam antibiotics, macrolides, quinolones, and vancomycin)
among variety of clinically significant species of bacteria
is becoming increasingly important global problem. Also a
number of recent clinical reports describe the increasing
occurrence of methicillin the resistant Staphylococcus aureus
(MRSA) which is the most disturbing cause of nosocomial
infections in developed countries [3, 4]. Infections caused
by these microorganisms pose a serious challenge to the
medicinal community and the need for an effective therapy
has led to search for novel antimicrobial agents.
Phenolic compounds are commonly known for their
antioxidant, anti-inflammatory, and antimicrobial activities
[5]. During the past years extensive evidences have been
accumulated to establish the efficiency of benzophenone
analogues as antimicrobial agent [6–10]. Benzophenone ana-
logue (garcinol) has been isolated from the stem bark of
Garcinia huillensis grown in Zaire and used in central-
African traditional medicine and also extracts obtained
from Rheedia brasiliensis fruit (bacupari) containing bioac-
tive compound of benzophenone analogous which showed
activity against Streptococcus mutans at low concentrations
(1.25–2.5 𝜇g/mL). Also prenylated benzophenone isolated
from roots of Cudrania cochinchinensis (Moraceae) was
tested for its antimicrobial activities against vancomycin-
resistant enterococci. This has exhibited chemotherapeuti-
cal activity against Gram-positive and Gram-negative cocci,
mycobacteria, and fungi [11–13]. Recently Selvi et al. have
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shown antifungal activity of benzophenone analogues, at its
lower concentration [14]. Besides chloro substituted ben-
zophenones have exhibited more antifungal activity [15].
The pharmacological effect of morpholine compounds
in different biological fields is of great importance for
researchers and investigators. Morpholine derivative plays an
important role in the treatment of several diseases. Hetero-
cyclic ring systems having morpholine nucleus have aroused
great interest in recent years due to their variety of biological
activities [16]. Morpholine derivatives were reported to pos-
sess antimicrobial activity [17, 18] and inflammatory activities
in albino rats [19]. Morpholine derivatives find their wide
spectrum of antimicrobial activity and exhibit anthelmintic,
bactericidal, and insecticidal activity [20, 21].
Another important pharmacophore group of morpholine
nucleus incorporated in a wide variety of therapeutically
important drugs, one of which is linezolid (PNU-10766,
commercially available antimicrobial drug), possess 4-(2-
fluorophenyl) morpholine moiety [22, 23]. In addition, series
of benzophenone derivatives, some of which contained a
morpholine group possess good antifungal and antibacterial
activities [24].
In continuation of our studies for the synthesized com-
pound [19], we report herein antibacterial and antifungal
activities of benzophenone-N-ethyl morpholine ethers.
2. Experimental Section
2.1. Chemistry: Materials and Methods. IR spectra were
recorded in Nujol on FT-IR Shimadz 8300 spectrophotome-
ter, 1H NMR spectra were recorded on a Bruker 300MHz
NMR spectrophotometer in CDCl
3
, and chemical shift was
recorded in parts per million down field from tetram-
ethylsilane. Mass spectra were obtained with a VG70-70H
spectrophotometer and important fragments are given with
the relative intensities in the brackets. Elemental analysis
results are within 0.4% of the calculated value.
2.2. General Procedure for the Synthesis of Substituted
Benzophenone-N-ethyl Morpholine Ethers (5a–j). Substi-
tuted 2-methylphenyl benzoates (3a–j) were synthesized by
stirring 2-methyl phenol (1, 1 equivalent) with corresponding
benzoyl chlorides (2a–j, 1 equivalent) for 30 minutes in
alkaline medium using 10% sodium hydroxide solution with
excellent yield. Substituted hydroxyl benzophenones (4a–j)
were synthesized by refluxing a mixture of 3a–j (1 equiv-
alent) and anhydrous aluminum chloride (1.5 equivalents)
for 20 minutes. Condensation of 4a–j (1 equivalent) with
4-(2-chloroethyl) morpholine hydrochloride (1 equivalent)
for 3 hours in presence of anhydrous potassium carbonate (1.5
equivalents) and dimethyl sulphoxide furnished substituted
benzophenone-N-ethyl morpholine ethers (5a–j) with good
yield. The compounds 5a-j were characterized by IR, 1H
NMR, and mass spectrophotometer [19].
2.3. Biology: Materials and Methods for the Antimicrobial
Activity. Streptomycin and ciprofloxacin (Sigma) were
used as positive controls against bacteria. Fluconazole and
ketoconazole (Himedia, Mumbai) were used as positive
controls against fungi.
2.3.1. Tested Microbes. The following gram-positive bacteria
were used for the experiments; S. aureus, S. aureus (MRSA),
E. aerogenes, and M. luteus. The gram-negative bacteria
includedK. pneumoniae, S. typhimurium, S. paratyphi-B, and
P. vulgaris. In addition, fungi C. albicans, B. cinerea, M.
pachydermatis, and C. krusei were also used for the experi-
ments. All cultures were obtained from the Department of
Microbiology, Manasagangotri, Mysore.
2.3.2. Preparation of Inoculums. Bacterial inoculums were
prepared by growing cells in Mueller Hinton Broth (MHA)
(Himedia) for 24 h at 37∘C. These cell suspensions were
diluted with sterile MHB to provide initial cell counts of
about 104CFU/mL. The filamentous fungi were grown on
sabouraud dextrose agar (SDA) slants at 28∘C for 10 days and
the spores were collected using sterile doubled distilled water
and homogenized.
2.3.3. Disc Diffusion Assay. Antibacterial activity was carried
out using a disc diffusion method [25]. Petri plates were
prepared with 20mL of sterile Mueller Hinton Agar (MHA)
(Himedia, Mumbai). The test cultures were swabbed on the
top of the solidified media and allowed to dry for 10mins.
The tests were conducted at 1000 𝜇g/disc. The loaded discs
were placed on the surface of the medium and left for 30min
at room temperature for compound diffusion. Negative
control was prepared using respective solvent. Streptomycin
(10 𝜇g/disc) was used as positive control. The plates were
incubated for 24 h at 37∘C for bacteria and 48 h at 27∘C for
fungi. Zone of inhibition was recorded inmillimeters and the
experiment was repeated twice.
2.3.4. Minimum Inhibitory Concentration (MIC). Minimum
inhibitory concentration studies of synthesized compounds
were performed according to the standard reference method
for bacteria [26] and filamentous fungi [27]. Required con-
centrations (1000 𝜇g/mL, 500𝜇g/mL, 250𝜇g/mL, 125𝜇g/mL,
62.5 𝜇g/mL, 31.25 𝜇g/mL, and 15.62𝜇g/mL) of the compound
were dissolved in DMSO (2%) and diluted to give serial
two-fold dilutions that were added to each medium in 96
well plates. An inoculum of 100mL from each well was
inoculated. The antifungal agent’s ketoconazole, fluconazole
for fungi and streptomycin, and ciprofloxacin for bacteria
were included in the assays as positive controls. For fungi,
the plates were incubated for 48–72 h at 28∘C and for bacteria
the plates were incubated for 24 h at 37∘C.TheMIC for fungi
was defined as the lowest extract concentration, showing no
visible fungal growth after incubation time. 5ml of tested
broth was placed on the sterile MHA plates for bacteria and
incubated at respective temperatures. The MIC for bacteria
was determined as the lowest concentration of the compound
inhibiting the visual growth of the test cultures on the agar
plate.
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Table 1: In vitro antibacterial activity of compounds 5a–j.
Compounds
Zone of inhibition in mm
Gram-positive bacteria Gram-negative bacteria
S. aureus S. aureus (MRSA) E. aerogenls M. luteus K. pneumonia S. typhimurium S. Paratyphi-B P. vulgaris
5a 10 9 9 11 9 11 8 12
5b 13 11 10 11 9 10 8 9
5c 15 12 14 13 12 15 13 11
5d 16 12 14 12 10 17 8 13
5e 20 18 22 24 25 26 29 28
5f 24 14 19 17 15 24 9 18
5g 25 15 15 19 14 21 13 17
5h 23 12 18 19 12 21 9 14
5i 19 9 12 15 14 17 11 12
5j 11 8 9 12 11 10 8 9
Streptomycin 16 20 21 24 21 22 17 23
Table 2: In vitro antifungal activity of compounds 5a–j.
Compounds Zone of inhibition in mm
C. albicans B. cinerea M. pachydermatis C. krusei
5a 8 9 10 11
5b 9 8 10 7
5c 14 10 13 13
5d 10 9 15 14
5e 18 16 21 23
5f 14 10 11 16
5g 9 12 13 19
5h 13 15 11 14
5i 12 10 13 20
5j 10 9 12 15
Ketoconazole 21 11 25 17
3. Result and Discussion
The reaction sequence for the title compounds is outlined in
Scheme 1. Compounds 5a–j have been prepared as previously
reported by our group [19]. The antimicrobial activities of
synthesized compounds were screened against eight bac-
teria and four fungi using in vitro disc diffusion method.
The results revealed that most of the synthesized com-
pounds exhibited antimicrobial activities against Staphylococ-
cus aureus, Staphylococcus aureus (MRSA),Enterobacter aero-
genes, Micrococcus luteus, Klebsiella pneumoniae, Salmonella
typhimurium, Salmonella paratyphi-B, Proteus vulgaris, Can-
dida albicans,Botyritis cinerea,Malassesia pachydermatis, and
Candida krusei organisms. The results are summarized in
Tables 1 and 2. Compounds 5e, 5f, 5g, 5h, and 5i showed
good activity more than standard drug against S. aureus.
Compound 5e with chlorogroup at meta position in phenyl
ring showed good activity against both Gram-positive and
Gram-negative bacteria among all synthesized compounds
compared with the standard. Among compounds 5b–d in
which methyl group is substituted at para, ortho, and meta
position, respectively, compound 5d showed good activity
against S. aureus and S. typhimurium Compound 5e showed
significant antifungal activity against B. cinerea and C. krusei
and compound 5hwith fluoro group at para position showed
more activity against B. cinerea. Similarly compound 5g
with bromo group at para position and 5i with two chloro
groups at ortho and para position showed more activity
against C. krusei compared to standard drug. In contrast,
compounds 5awithmethoxy group, 5b–dwithmethyl group,
and 5j without any substituent exhibited lowest activity and
this can be attributed to the electron releasing effect. The
MIC values of active compounds 5c–i against bacteria and
fungi are given in Tables 3 and 4. Significant MIC values
were observed against Gram-positive and Gram-negative
bacteria. Compounds 5d–h showed good activity against S.
aureus. In comparison to compound 5i, in compounds 5d
and 5e, the potency against S. aureus has been increased by
onefold. Interestingly the presence of halo group in phenyl
ring in compounds 5g and 5h increased the potency against
S. aureus by twofold. In comparison to compound 5i in
compound 5e the potency is increased by twofold against
bacteria S. paratyphi-B, threefold by S. aureus (MRSA) and
S. typhimurium, fourfold by M. luteus, K. pneumonia, and
fivefold by E. aerogens. Besides, the potency of compound 5e
is increased by twofold against fungi B. cinerea, three fold by
C. krusei and fourfold by C. albicans compared to compound
5i. In general, compound 5e showed better activity than
standard drugs for most of the tested bacteria and fungi.
4. Conclusion
In conclusion, this study is considered with respect to syn-
thesis of morpholine analogues 5a–j as new budding antimi-
crobials. These novel compounds were evaluated for their
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Table 3: MIC (𝜇g/mL) of compounds 5a–j against tested bacteria.
Compounds
Minimum inhibitory concentration (𝜇g/ mL)
Gram-positive bacteria Gram-negative bacteria
S. aureus S. aureus (MRSA) E. aerogenes M. luteus K. pneumoniae S. typhimurium S. Paratyphi-B P. vulgaris
5c 250 500 250 250 500 62.5 500 500
5d 31.25 125 125 63.5 63.5 250 125 250
5e 31.25 62.5 15.62 15.62 15.62 15.62 125 <15.62
5f 15.62 12.5 62.5 12.5 250 15.62 500 125
5g 15.62 250 250 32.5 250 31.25 500 62.5
5h 15.62 250 62.5 62.5 550 31.25 500 125
5i 62.5 500 500 250 250 125 500 500
Streptomycin 6.25 >100 25 6.25 6.25 30 ni 6.25
Ciprofloxacin <0.78 >100 <0.78 >100 <0.78 >100 6.25 <0.78
ni: no inhibition.
activities against eight bacteria and four fungi. Compound
5e with chloro group at meta position in phenyl ring was
found to be more than 1.6 times active against S. aureus
(MRSA) bacteria than streptomycin and ciprofloxacin and
moreover more than 6.4 times active againstM. luteus and S.
typhimurium bacteria than ciprofloxacin. Compound 5e was
also found to bemore than 3.2 times active againstC. albicans
fungi than fluconazole. In contrast, compounds 5a with
methoxy group and 5b–dwithmethyl group exhibited lowest
activity and this can be attributed to the electron releasing
effect. These results showed that synthesized compound 5e
might be a potential antibacterial and antifungal agent.
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Table 4: MIC (𝜇g/mL) of compounds 5a–j against tested fungi.
Compounds Minimum inhibitory concentration (𝜇g/mL)
C. albicans B. cinerea M. pachydermatis C. krusei
5c 125 500 250 125
5d 250 250 125 125
5e 31.5 125 250 31.5
5f 250 250 500 250
5g 500 500 250 250
5h 500 250 500 250
5i 500 500 250 250
Fluconazole >100 ni 12.5 12.5
Ketoconazole 25 25 15 15
ni: no inhibition.
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